Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Red cell phospholipids in schizophrenia

A Lautin, D M Cordasco, D J Segarnick

    Life Sciences
    |December 27, 1982
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Are people at risk of psychosis also at risk of suicide and self-harm? A systematic review and meta-analysis.

    Psychological medicine·2014
    Same author

    Stress-related genes and heroin addiction: a role for a functional FKBP5 haplotype.

    Psychoneuroendocrinology·2014
    Same author

    First-, second-, third-line therapy for mRCC: benchmarks for trial design from the IMDC.

    British journal of cancer·2014
    Same author

    A 2 weeks on and 1 week off schedule of sunitinib is associated with decreased toxicity in metastatic renal cell carcinoma.

    European journal of cancer (Oxford, England : 1990)·2014
    Same author

    Portion weights of food served in English schools: have they changed following the introduction of nutrient-based standards?

    Journal of human nutrition and dietetics : the official journal of the British Dietetic Association·2013
    Same author

    Influence of reported study design characteristics on intervention effect estimates from randomised controlled trials: combined analysis of meta-epidemiological studies.

    Health technology assessment (Winchester, England)·2012
    Same journal

    Corrigendum to "Adipose stem cells-derived microvesicles and chicken egg-derived exosomes attenuate cardiac ischemia/reperfusion injury through AKT/ERK/Nrf2/HO-1 axis to inhibit apoptosis and inflammation and restore autophagy" [Life Sci. 395 (2026) 124364].

    Life sciences·2026
    Same journal

    MAGED1 stabilizes NEUROD1 to promote Per3 expression in the pineal gland.

    Life sciences·2026
    Same journal

    TNF-centered network pharmacology and molecular modeling of selected Andrographis paniculata compounds in hypertension.

    Life sciences·2026
    Same journal

    Retraction notice to "Beneficial effect of Calculus Bovis Sativus on 17α-ethynylestradiol-induced cholestasis in the rat" [Life Sci. 113 (2014) 22-30].

    Life sciences·2026
    Same journal

    Soluble PD-1 drives renal fibrosis in CKD by disrupting immune homeostasis: Therapeutic mitigation via a targeted sPD-1 sequestration strategy.

    Life sciences·2026
    Same journal

    METTL1 promotes hepatic steatosis by mediating m<sup>7</sup>G modification of ALOX15B mRNA.

    Life sciences·2026
    See all related articles

    This study investigated red blood cell (RBC) phospholipids in schizophrenia. Unlike previous findings, no differences in phosphatidylserine levels were observed between schizophrenic patients and control groups.

    Area of Science:

    • Biochemistry
    • Neuroscience
    • Cell Biology

    Background:

    • Phospholipid composition of red blood cells (RBCs) is crucial for membrane integrity.
    • Alterations in RBC phospholipids have been implicated in various neurological disorders, including schizophrenia.
    • Previous studies suggested elevated phosphatidylserine levels in schizophrenic patients' RBCs.

    Purpose of the Study:

    • To accurately determine and compare phospholipid profiles in RBCs from individuals with schizophrenia and healthy controls.
    • To investigate potential discrepancies in phosphatidylserine levels reported in prior research.

    Main Methods:

    • Utilized three distinct RBC preparations and two different extraction techniques for comprehensive analysis.
    • Employed thin-layer chromatography (TLC) and high-performance liquid chromatography (HPLC) for phospholipid separation.

    Related Experiment Videos

  • Quantified phospholipids using phosphorus analysis and ultraviolet absorption spectroscopy.

    • Main Results:

    • Phospholipid profiles in RBCs of schizophrenic patients were found to be consistent with those of control groups.
    • No significant differences in phosphatidylserine levels were detected between the schizophrenic and control populations.
    • The findings align with established phospholipid values reported for normal individuals.

    Conclusions:

    • The study did not find evidence supporting elevated phosphatidylserine levels in the RBCs of schizophrenic patients.
    • These results contrast with some previous reports, highlighting the need for further investigation into RBC phospholipid abnormalities in schizophrenia.
    • Standardized methodologies are essential for reliable comparisons of phospholipid profiles across different studies.